Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Slikker

Showing results (11-20 of 217) with videos related to

Pageof 22
Sort By:
Annals of the New York Academy of Sciences|November 25, 1997
Current and future approaches to neurotoxicity risk assessmentW Slikker, T J Sobotka
Proceedings of the Western Pharmacology Society|January 1, 1985
Developmental neuropharmacology/neurotoxicologyW Slikker, M G Paule
Annals of the New York Academy of Sciences|September 15, 1995
Risk assessment strategies for neuroprotective agentsW Slikker, D W Gaylor
Brain Research|October 16, 1999
Hyperthermia-enhanced serotonin (5-HT) depletion resulting from D-fenfluramine (D-Fen) exposure does not evoke a glial-cell response in the central nervous system of ratsC W Stewart, W Slikker
Life Sciences|November 26, 1999
Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-fenfluramine exposure is preventableC W Stewart, W Slikker
Annals of the New York Academy of Sciences|September 15, 1995
Biologically based dose-response model for neurotoxicity risk assessmentW Slikker, D W Gaylor
Neurotoxicology|January 11, 1990
Risk assessment for neurotoxic effectsD W Gaylor, W Slikker
Life Sciences|June 27, 1983
Ethynylestradiol-17 beta D-ring glucuronide conjugates are potent cholestatic agents in the ratM Vore, H Hadd, W Slikker
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1981
Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the ratM Meyers, W Slikker, M Vore
Brain Research|October 29, 1993
Intracranial injection of Fluoro-Gold results in the degeneration of local but not retrogradely labeled neuronsL C Schmued, C Beltramino, W Slikker
Pageof 22

Showing results (11-20 of 217) with videos related to

Sort By:
Pageof 22
Annals of the New York Academy of Sciences|November 25, 1997
Current and future approaches to neurotoxicity risk assessmentW Slikker, T J Sobotka
Proceedings of the Western Pharmacology Society|January 1, 1985
Developmental neuropharmacology/neurotoxicologyW Slikker, M G Paule
Annals of the New York Academy of Sciences|September 15, 1995
Risk assessment strategies for neuroprotective agentsW Slikker, D W Gaylor
Brain Research|October 16, 1999
Hyperthermia-enhanced serotonin (5-HT) depletion resulting from D-fenfluramine (D-Fen) exposure does not evoke a glial-cell response in the central nervous system of ratsC W Stewart, W Slikker
Life Sciences|November 26, 1999
Hyperthermia-enhanced serotonin (5-HT) depletion resulting from d-fenfluramine exposure is preventableC W Stewart, W Slikker
Annals of the New York Academy of Sciences|September 15, 1995
Biologically based dose-response model for neurotoxicity risk assessmentW Slikker, D W Gaylor
Neurotoxicology|January 11, 1990
Risk assessment for neurotoxic effectsD W Gaylor, W Slikker
Life Sciences|June 27, 1983
Ethynylestradiol-17 beta D-ring glucuronide conjugates are potent cholestatic agents in the ratM Vore, H Hadd, W Slikker
The Journal of Pharmacology and Experimental Therapeutics|July 1, 1981
Steroid D-ring glucuronides: characterization of a new class of cholestatic agents in the ratM Meyers, W Slikker, M Vore
Brain Research|October 29, 1993
Intracranial injection of Fluoro-Gold results in the degeneration of local but not retrogradely labeled neuronsL C Schmued, C Beltramino, W Slikker
Pageof 22